Correlation Between Fate Therapeutics and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Regeneron Pharmaceuticals.
Diversification Opportunities for Fate Therapeutics and Regeneron Pharmaceuticals
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Fate and Regeneron is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Fate Therapeutics is 4.02 times more volatile than Regeneron Pharmaceuticals. It trades about -0.14 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.34 per unit of volatility. If you would invest 94,139 in Regeneron Pharmaceuticals on September 23, 2024 and sell it today you would lose (23,954) from holding Regeneron Pharmaceuticals or give up 25.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Fate Therapeutics |
Regeneron Pharmaceuticals |
Fate Therapeutics and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Regeneron Pharmaceuticals
The main advantage of trading using opposite Fate Therapeutics and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Regeneron Pharmaceuticals vs. Fate Therapeutics | Regeneron Pharmaceuticals vs. Sana Biotechnology | Regeneron Pharmaceuticals vs. Caribou Biosciences | Regeneron Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges |